UNC School of Medicine researchers use new imaging methods to show that running burns fat in bone marrow, with benefits for bone health. The best effect was seen in obese mice. Maya Styner, MD, was the study's lead author.
In their study of the IRS-1 protein, researchers at the University of North Carolina found a new lead for reversing or preventing heart disease associated with diabetes.
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.
